- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Nasdaq
Wall Street JournalEN
C
COLL
Collegium Pharmaceutical Inc
45.00
-0.18-0.40%After Hours: 45.00 0.00 0.00%16:12 02/20 EST
OPEN/PREV CLOSE45.25/45.18
TODAY RANGE44.82-45.93
VOL227.11K
MARKET CAP1.42B
52 WEEK RANGE23.23-50.79
AVG VOL (3M)472.44K
% TURNOVER0.72%
TURNOVER--
P/E (TTM)28.07
% RANGE2.17%
EPS(TTM)1.603
P/E(FORWARD)23.20
P/B5.17
BVPS8.70
DIVIDEND--
P/S2.241
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.40B
SHARES OUTSTANDING31.61M
NEXT EARNINGS02/25-03/02
FREE FLOAT31.09M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·02/10 14:26
Collegium Pharmaceutical price target raised to $58 from $55 at Truist
TipRanks·02/05 17:45
Collegium Pharmaceutical management to meet with Truist
Simply Wall St·02/02 21:18
What Collegium Pharmaceutical (COLL)'s Revenue Surge and Low Valuation Means For Shareholders
Seeking Alpha·01/22 03:45
Collegium Pharmaceutical: Buying The Projected Growth For 2026
Simply Wall St·01/19 11:13
A Look At Collegium Pharmaceutical (COLL) Valuation After Recent Share Price Pullback
Simply Wall St·01/16 16:25
Is It Too Late To Consider Collegium Pharmaceutical (COLL) After A 40% One Year Gain?
Simply Wall St·01/15 12:24
Does Collegium’s 2026 Revenue Guidance After Insider Sales Change The Bull Case For COLL?
Seeking Alpha·01/15 11:49
Trump admin rolls back $2B in mental health, addiction grant cuts—report
Simply Wall St·01/10 08:15
A Look At Collegium Pharmaceutical (COLL) Valuation After 2026 Guidance And Nucynta Authorized Generic Agreements
Dow Jones·01/09 15:11
Collegium Pharmaceutical Is Maintained at Overweight by Barclays
Dow Jones·01/09 15:11
Collegium Pharmaceutical Price Target Cut to $56.00/Share From $58.00 by Barclays
Same Industry
Name/Symbol
Change%
Price